PIXUVRI Trademark

Trademark Overview

On Wednesday, November 27, 2019, a trademark application was filed for PIXUVRI with the United States Patent and Trademark Office. The USPTO has given the PIXUVRI trademark a serial number of 79275321. The federal status of this trademark filing is REGISTERED as of Tuesday, June 30, 2020. This trademark is owned by BIOFARMA. The PIXUVRI trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations for the treatment of immunological, inflammatory diseases and oncological disorders
pixuvri

General Information

Serial Number79275321
Word MarkPIXUVRI
Filing DateWednesday, November 27, 2019
Status700 - REGISTERED
Status DateTuesday, June 30, 2020
Registration Number6087943
Registration DateTuesday, June 30, 2020
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, April 14, 2020

Trademark Statements

Goods and ServicesPharmaceutical preparations for the treatment of immunological, inflammatory diseases and oncological disorders

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateTuesday, January 7, 2020
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameBIOFARMA
Party Type30 - Original Registrant
Legal Entity Type34 - NOT AVAILABLE
AddressFR
Party NameBIOFARMA
Party Type20 - Owner at Publication
Legal Entity Type34 - NOT AVAILABLE
AddressFR
Party NameBIOFARMA
Party Type10 - Original Applicant
Legal Entity Type34 - NOT AVAILABLE
AddressFR

Trademark Events

Event DateEvent Description
Saturday, November 14, 2020FINAL DECISION TRANSACTION PROCESSED BY IB
Monday, October 26, 2020FINAL DISPOSITION NOTICE SENT TO IB
Monday, October 26, 2020FINAL DISPOSITION PROCESSED
Wednesday, September 30, 2020FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Tuesday, June 30, 2020REGISTERED-PRINCIPAL REGISTER
Tuesday, April 14, 2020OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, April 14, 2020PUBLISHED FOR OPPOSITION
Wednesday, March 25, 2020NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Monday, March 9, 2020APPROVED FOR PUB - PRINCIPAL REGISTER
Monday, February 24, 2020TEAS CHANGE OF CORRESPONDENCE RECEIVED
Monday, February 24, 2020APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Monday, February 24, 2020ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Monday, February 24, 2020TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Monday, February 24, 2020TEAS CHANGE OF OWNER ADDRESS RECEIVED
Friday, February 21, 2020REFUSAL PROCESSED BY IB
Thursday, February 6, 2020NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Thursday, February 6, 2020REFUSAL PROCESSED BY MPU
Tuesday, January 14, 2020NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Monday, January 13, 2020NON-FINAL ACTION WRITTEN
Saturday, January 11, 2020APPLICATION FILING RECEIPT MAILED
Friday, January 10, 2020ASSIGNED TO EXAMINER
Tuesday, January 7, 2020NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Tuesday, December 31, 2019LIMITATION FROM ORIGINAL APPLICATION ENTERED
Thursday, December 26, 2019SN ASSIGNED FOR SECT 66A SUBSEQ DESIG FROM IB

Related Keywords

pixuvri diseases oncological disorders inflammatory immunological preparations treatment pharmaceutical